Nav: Home

Researchers unlock secrets of cell division, define role for protein elevated in cancer

January 14, 2020

Researchers at Princeton University have successfully recreated a key process involved in cell division in a test tube, uncovering the vital role played by a protein that is elevated in over 25% of all cancers. The researchers' findings, described in a pair of papers published in the journals eLife and Nature Communications, are a key step toward recreating the entire cell division machinery and could lead to new therapies aimed at preventing the growth of cancer cells.

When cells divide, a spindle-like structure composed of thousands of filaments called microtubules attaches to chromosomes and pulls equal numbers of them into each newly forming cell. Each microtubule is assembled from individual tubulin molecules and, because errors in chromosome segregation can lead to cancer, it is vital that they assemble into microtubules at the right time and place to form a functional spindle apparatus. Branching microtubule nucleation, in which a new microtubule forms from the side of an existing one, is crucial to this process because it allows the cell to form large numbers of microtubules that all point toward chromosomes, enabling their capture by the spindle.

Branching microtubule nucleation depends on several pieces of molecular machinery. One piece, called the gamma-tubulin ring complex (γ-TuRC), initiates the assembly of tubulin molecules into microtubules, while another, known as the augmin complex, recruits γ-TuRC to the side of existing microtubules. A protein called TPX2, whose levels are elevated in over 25% of all cancers, is also involved in branching microtubule nucleation. Elevated TPX2 levels lead to both aberrant microtubule assembly in cells and poor outcomes in cancer patients. But how TPX2 works with augmin and γ-TuRC to mediate branching microtubule nucleation and spindle assembly has remained unknown.

"To better understand the mechanism of branching microtubule nucleation, we set out to reconstitute the process outside of the cell using purified proteins," said Sabine Petry, assistant professor of molecular biology at Princeton.

In the eLife study, graduate students Raymundo Alfaro-Aco and Akanksha Thawani describe how they recreated branching microtubule nucleation in a test tube. One key finding from the study is that, like augmin, TPX2 can bind to microtubules and recruit γ-TuRC to initiate branching microtubule nucleation. Another surprising finding was that TPX2 also helps recruit augmin to microtubules, further enhancing the recruitment of γ-TuRC.

"Branching microtubule nucleation therefore occurs most efficiently when augmin, TPX2, and γ-TuRC are all present," Alfaro-Aco said. "Surprisingly, TPX2 lies at the very heart of controlling this reaction, despite being only a single protein amongst the large multi-subunit complexes augmin and γ-TuRC."

In the Nature Communications paper, Petry and her former graduate student Matthew King further reveal that TPX2 behaves like a liquid in promoting branching microtubule nucleation. Specifically, TPX2 forms a liquid layer on the surface of existing microtubules that beads up into tubulin-containing droplets, much like morning dew on spider webs. The researchers found that TPX2 and tubulin can condense together to form liquid-like droplets through a phase-separation mechanism identical to the one that causes oil droplets to form in water. New microtubules can form from these TPX2-tubulin droplets and, because the droplets condense on the surface of existing microtubules, this results in the formation of branched microtubule structures.

"The study suggests that the co-condensation of TPX2 and tubulin creates a local reservoir of tubulin on a pre-existing microtubule that may be necessary to efficiently promote branching microtubule nucleation," King said.

Together, both studies reveal that TPX2, somewhat overlooked before, is the lynchpin of branching microtubule nucleation. It travels to microtubules first to assemble all of the other components that ultimately give rise to a branching microtubule, and it does this while behaving like a liquid. Petry and colleagues think that cellular signals may regulate TPX2 condensation to ensure that it only occurs when a cell is dividing and needs to form a spindle. "Our findings on the behavior of TPX2 may guide future therapeutic efforts aimed at modulating cell division," Petry said. "In addition, our reconstitution of branching microtubule nucleation is an important step toward reconstituting the entire spindle apparatus, as well as other cellular structures that depend on this microtubule assembly pathway."
-end-
The work published in both papers was supported by the National Institutes of Health (NIH), the Pew Scholars Program in the Biomedical Sciences, and the David and Lucile Packard Foundation. The work published in eLife was additionally supported by a Howard Hughes Medical Institute Gilliam Fellowship, a National Science Foundation Graduate Research Fellowship, and an American Heart Association predoctoral fellowship.

Princeton University

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.